- Cambridge, Mass.-based Sarepta Therapeutics’ drug eteplirsen represents the first approved treatment for Duchenne’s muscular dystrophy.
- Lomaira is intended to help obese and overweight patients lose weight.
- India-based AuroBindo Pharma’s drug dolutegravir is intended to treat patients with HIV.
- Kyleena is a T-shaped intrauterine device that releases levonorgestrel, a hormone that stops the womb lining from thickening and consequently prevents pregnancy.
- Taiwan-based Medeon Biodesign developed a port site closure device called AbClose.
- Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR may now be used as a first-line treatment to improve glycemic control in diabetic adults.
More articles on supply chain:
Supply chain tip of the week: Stick to facts not feelings
Wireless diagnostic device can detect flu strains within minutes
Self-directed robots are the new warehouse workers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
